Patents by Inventor Mathias Locher

Mathias Locher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combinations of flupirtine and sodium channel inhibiting substances for treating pains
    Patent number: 8557851
    Abstract: The invention relates to pharmaceutical combinations of potassium channel openers and sodium channel inhibitors, for treating pains which are accompanied by an increase in muscle tone.
    Type: Grant
    Filed: March 12, 2009
    Date of Patent: October 15, 2013
    Assignee: MEDA Pharma GmbH & Co. KG
    Inventors: Istvan Szelenyi, Kay Brune, Robert Hermann, Mathia Locher
  • ANTI-EpCAM IMMUNOGLOBULINS
    Publication number: 20120294873
    Abstract: The invention relates inter alia to a method of treating tumorous disease in a human patient by administering to the patient a human immunoglobulin specifically binding to the human EpCAM antigen, the immunoglobulin exhibiting a serum half-life of at least 15 days, the method comprising the step of administering the immunoglobulin no more frequently than once every week, preferably no more frequently than once every two weeks.
    Type: Application
    Filed: June 1, 2012
    Publication date: November 22, 2012
    Inventors: Malte Peters, Mathias Locher, Nadja Prang, Cornelia Quadt
  • COMBINATIONS OF RETIGABINE AND SODIUM CHANNEL INHIBITORS OR SODIUM CHANNEL-INFLUENCING ACTIVE COMPOUNDS FOR TREATING PAINS
    Publication number: 20100323987
    Abstract: The invention relates to pharmaceutical combinations of retigabine and sodium channel inhibitors for treating, pains which are accompanied by an increase in muscle tone.
    Type: Application
    Filed: August 30, 2010
    Publication date: December 23, 2010
    Applicant: Valeant Pharmaceuticals North America
    Inventors: Istvan SZELENYI, Kay BRUNE, Robert HERMANN, Mathias LOCHER
  • Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
    Patent number: 7799832
    Abstract: The invention relates to pharmaceutical combinations of retigabine and sodium channel inhibitors for treating pains which are accompanied by an increase in muscle tone.
    Type: Grant
    Filed: December 5, 2003
    Date of Patent: September 21, 2010
    Assignee: Valeant Pharmaceuticals North America
    Inventors: Istvan Szelenyi, Kay Brune, Robert Hermann, Mathias Locher
  • COMBINATIONS OF POTASSIUM CHANNEL OPENERS AND SODIUM CHANNEL INHIBITORS OR SODIUM CHANNEL-INFLUENCING ACTIVE COMPOUNDS FOR TREATING PAINS
    Publication number: 20090176814
    Abstract: The invention relates to pharmaceutical combinations of potassium channel openers and sodium channel inhibitors. for treating pains which are accompanied by an increase in muscle tone.
    Type: Application
    Filed: March 12, 2009
    Publication date: July 9, 2009
    Applicant: Valeant Pharmaceuticals North America
    Inventors: Istvan SZELENYI, Kay BRUNE, Robert HERMANN, Mathias LOCHER
  • Anti-EpCam Immunoglobulins
    Publication number: 20070274982
    Abstract: The invention relates inter alia to a method of treating tumorous disease in a human patient by administering to the patient a human immunoglobulin specifically binding to the human EpCAM antigen, the immunoglobulin exhibiting a serum half-life of at least 15 days, the method comprising the step of administering the immunoglobulin no more frequently than once every week, preferably no more frequently than once every two weeks.
    Type: Application
    Filed: February 9, 2005
    Publication date: November 29, 2007
    Inventors: Malte Peters, Mathias Locher, Nadja Prang, Cornelia Quadt
  • Novel combination of glucocorticoids and pde-4 inhibitors for treating respiratory diseases, allegic diseases, asthma and copd
    Publication number: 20050288265
    Abstract: The invention relates to a novel combination of a glucocorticoid, especially loteprednol, and at least one phospho-diesterase-4 inhibitor (PDE-4-inhibitor), especially hydroxyindole-derivative N-(3,5-dichloropyridine-4-yl)-2-[1-(4-fluorbenzyl)-5-hydroxyindole-3-yl]-2-oxoacetamide, for a simultaneous, sequential or separate administration in the treatment of respiratory diseases, allergic diseases, asthma and chronic obstructive pulmonary diseases (COPD).
    Type: Application
    Filed: August 4, 2003
    Publication date: December 29, 2005
    Inventors: Mathias Locher, Robert Hermann
  • Anti-EpCAM immunoglobulins
    Publication number: 20050180979
    Abstract: The invention relates inter alia to a method of treating tumorous disease in a human patient by administering to the patient a human immunoglobulin specifically binding to the human EpCAM antigen, the immunoglobulin exhibiting a serum half-life of at least 15 days, the method comprising the step of administering the immunoglobulin no more frequently than once every week, preferably no more frequently than once every two weeks.
    Type: Application
    Filed: February 13, 2004
    Publication date: August 18, 2005
    Inventors: Malte Peters, Mathias Locher, Nadja Prang, Cornelia Quadt
  • Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
    Publication number: 20050090547
    Abstract: The invention relates to pharmaceutical combinations of retigabine and sodium channel inhibitors for treating pains which are accompanied by an increase in muscle tone.
    Type: Application
    Filed: December 5, 2003
    Publication date: April 28, 2005
    Inventors: Istvan Szelenyi, Kay Brune, Robert Hermann, Mathias Locher
  • Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
    Publication number: 20050089559
    Abstract: The invention relates to pharmaceutical combinations of potassium channel openers and sodium channel inhibitors for treating pains which are accompanied by an increase in muscle tone.
    Type: Application
    Filed: December 5, 2003
    Publication date: April 28, 2005
    Inventors: Istvan Szelenyi, Kay Brune, Robert Hermann, Mathias Locher